Literature DB >> 3600912

Fatigue, acid-base and electrolyte changes with exhaustive treadmill exercise in hemodialysis patients.

A P Lundin, R A Stein, C D Brown, P LaBelle, F S Kalman, B G Delano, W F Heneghan, N A Lazarus, N Krasnow, E A Friedman.   

Abstract

Aerobic conditioning exercises have been shown to be beneficial for maintenance hemodialysis patients, but biochemical changes during exhaustive exercise in these functionally anephric patients have been less thoroughly studied. We evaluated serum biochemical changes in 7 patients during and after treadmill exercise to patient exhaustion. Duration of exercise was limited by lower leg fatigue without claudication. At exhaustion, only mild changes from baseline rest values were noted in arterial pH (7.39 +/- 0.03-7.33 +/- 0.04) and lactate (0.94 +/- 0.3-5.73 +/- 2.68 mmol/l) despite normal exercise-induced intracellular fluid shifts as evidenced by albumin concentration increases (44.9 +/- 2.8-49.3 +/- 3.1 g/l). Increases in serum K+ concentrations are also modest (change in K from baseline = 0.87 +/- 0.22 mmol/l). An explanation for these minimal biochemical alterations at exhaustion is unclear, but could relate to exercise being limited well below estimated maximum cardiac output and muscle O2 extraction levels by early, unexplained muscle fatigue. Fatigue in hemodialysis patients does not appear to be due to muscle hypoxia.

Entities:  

Mesh:

Year:  1987        PMID: 3600912     DOI: 10.1159/000184301

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

1.  Portable, Non-Invasive Fall Risk Assessment in End Stage Renal Disease Patients on Hemodialysis.

Authors:  Thurmon E Lockhart; Adam T Barth; Xiaoyue Zhang; Rahul Songra; Emaad Abdel-Rahman; John Lach
Journal:  ACM Trans Comput Hum Interact       Date:  2010       Impact factor: 2.351

2.  Spiroergometric performance of children and adolescents with chronic renal failure.

Authors:  K E Bonzel; B Wildi; M Weiss; K Schärer
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.